Argent BioPharma Limited MXC.AX Stock
Argent BioPharma Limited Price Chart
Argent BioPharma Limited MXC.AX Financial and Trading Overview
| Argent BioPharma Limited stock price | 0.42 AUD |
| Previous Close | 0.006 AUD |
| Open | 0.006 AUD |
| Bid | 0.005 AUD x 0 |
| Ask | 0.006 AUD x 0 |
| Day's Range | 0.005 - 0.006 AUD |
| 52 Week Range | 0.005 - 0.02 AUD |
| Volume | 3.11M AUD |
| Avg. Volume | 3.24M AUD |
| Market Cap | 20.1M AUD |
| Beta (5Y Monthly) | 1.254406 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.04 AUD |
MXC.AX Valuation Measures
| Enterprise Value | 25.44M AUD |
| Trailing P/E | N/A |
| Forward P/E | -0.08571429 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.1770606 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.287 |
| Enterprise Value/EBITDA | -1.552 |
Trading Information
Argent BioPharma Limited Stock Price History
| Beta (5Y Monthly) | 1.254406 |
| 52-Week Change | -70.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 AUD |
| 52 Week Low | 0.005 AUD |
| 50-Day Moving Average | 0.00775 AUD |
| 200-Day Moving Average | 0.01 AUD |
MXC.AX Share Statistics
| Avg. Volume (3 month) | 3.24M AUD |
| Avg. Daily Volume (10-Days) | 4.17M AUD |
| Shares Outstanding | 3.35B |
| Float | 2.54B |
| Short Ratio | N/A |
| % Held by Insiders | 11.82% |
| % Held by Institutions | 11.46% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -342.52% |
| Gross Margin | 24.71% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.50% |
| Return on Equity (ttm) | -307.40% |
Income Statement
| Revenue (ttm) | 4.81M AUD |
| Revenue Per Share (ttm) | 0.002 AUD |
| Quarterly Revenue Growth (yoy) | 3.10% |
| Gross Profit (ttm) | 562.87K AUD |
| EBITDA | -16385803 AUD |
| Net Income Avi to Common (ttm) | -23344456 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.13M AUD |
| Total Cash Per Share (mrq) | 0 AUD |
| Total Debt (mrq) | 10.03M AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.392 |
| Book Value Per Share (mrq) | -0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13518810 AUD |
| Levered Free Cash Flow (ttm) | -8994122 AUD |
Profile of Argent BioPharma Limited
| Country | Australia |
| State | WA |
| City | West Perth |
| Address | 1202 Hay Street |
| ZIP | 6005 |
| Phone | 61 8 6382 3390 |
| Website | https://mgcpharma.com.au |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.
Q&A For Argent BioPharma Limited Stock
What is a current MXC.AX stock price?
Argent BioPharma Limited MXC.AX stock price today per share is 0.42 AUD.
How to purchase Argent BioPharma Limited stock?
You can buy MXC.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Argent BioPharma Limited?
The stock symbol or ticker of Argent BioPharma Limited is MXC.AX.
Which industry does the Argent BioPharma Limited company belong to?
The Argent BioPharma Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Argent BioPharma Limited have in circulation?
The max supply of Argent BioPharma Limited shares is 43.85M.
What is Argent BioPharma Limited Price to Earnings Ratio (PE Ratio)?
Argent BioPharma Limited PE Ratio is 0.00000000 now.
What was Argent BioPharma Limited earnings per share over the trailing 12 months (TTM)?
Argent BioPharma Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Argent BioPharma Limited company belong to?
The Argent BioPharma Limited sector is Healthcare.